Prostate
-
Publication Venue For
- Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population. 2021
- Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapy.. 80:1244-1252. 2020
- Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.. 79:1752-1761. 2019
- E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.. 79:1226-1237. 2019
- Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer.. 79:1106-1116. 2019
- DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations.. 79:657-666. 2019
- Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.. 79:604-613. 2019
- HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.. 79:414-424. 2019
- SRRM4 gene expression correlates with neuroendocrine prostate cancer.. 79:96-104. 2019
- Germline mutations in PPFIBP2 are associated with lethal prostate cancer.. 78:1222-1228. 2018
- A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.. 78:607-615. 2018
- Rare germline mutations in African American men diagnosed with early-onset prostate cancer.. 78:321-326. 2018
- Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.. 78:266-277. 2018
- Genetic factors influencing prostate cancer risk in Norwegian men.. 78:186-192. 2018
- Molecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients.. 78:17-24. 2018
- Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.. 77:446-457. 2017
- Is PSA related to serum cholesterol and does the relationship differ between black and white men?. 75:1877-1885. 2015
- A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate.. 75:1447-1453. 2015
- Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.. 75:836-844. 2015
- Carbohydrate intake, glycemic index and prostate cancer risk.. 75:430-439. 2015
- Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.. 75:381-389. 2015
- Patient preferences for treatments to delay bone metastases.. 74:1488-1497. 2014
- Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways.. 73:754-762. 2013
- The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model.. 73:449-454. 2013
- PDEF in prostate cancer.. 72:592-596. 2012
- Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: Racial differences.. 72:173-180. 2012
- Emerging treatment options for patients with castration-resistant prostate cancer.. 72:338-349. 2012
- Racial differences in prostate cancer risk remain among US servicemen with equal access to care.. 70:727-734. 2010
- Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.. 69:520-527. 2009
- Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy.. 68:1380-1386. 2008
- ERAP75 functions as a coactivator to enhance estrogen receptor alpha transactivation in prostate stromal cells.. 68:1273-1282. 2008
- Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial. 2017